LTGO NASDAQ
Latigo Biotherapeutics Inc.
1W: +6.7%
1M: -11.0%
YTD: -15.2%
$15.12
-0.14 (-0.92%)
After Hours: $15.14 (+0.03, +0.17%)
Weekly Expected Move ±12.5%
$11
$13
$15
$17
$19
Credit Risk of going bust: not rated Bonds: none of note held by US funds details ▾
Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$5.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$917.9M
52W Range13.5-25.93
Volume165,322
Avg Volume353,284
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEONima Farzan
Employees66
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2026-08-07
Websitelatigobio.com
1300 Rancho Conejo Boulevard, Suite 305
Thousand Oak, CA 91320
US
Thousand Oak, CA 91320
US
About Latigo Biotherapeutics Inc.
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
Latest News
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026
LTGO|Latigo Biotherapeutics Ord Shs|Price:18.000| - TradingKey
Latigo Biotherapeutics (NASDAQ:LTGO) Shares Down 4.9% - Should You Sell? - MarketBeat
Latigo Biotherapeutics, Inc.(NasdaqGS: LTGO) added to S&P TMI Index - marketscreener.com
Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) Short Interest Up 129.5% in August - MarketBeat
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Sanofi | C-Conversion | 494,800 | — | 2026-08-10 |
| Sanofi | C-Conversion | 177,978 | — | 2026-08-10 |
| Sanofi | C-Conversion | 494,800 | — | 2026-08-10 |
| Sanofi | C-Conversion | 177,978 | — | 2026-08-10 |
| 5AM Ventures VI, L.P | C-Conversion | 4,975,543 | — | 2026-08-10 |